Stay updated on Dolutegravir in Pregnancy Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.

Latest updates to the Dolutegravir in Pregnancy Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA sitewide NIH notice appears above the unavailable study record, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedAccess to the study page now returns a 403 Forbidden error page, replacing the previous study content. This indicates an access/permissions issue rather than a content update to the study record.SummaryDifference19%

- Check65 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This appears to be a minor administrative update rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Dolutegravir in Pregnancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.